Y. Hashimoto

Prediction of Effect of Interferon on Chronic Hepatitis C

M. Mori, T. Nagamine, Tetsurou Sekiguchi, 1997, Digestive Diseases and Sciences.

Severe manifestation of acute hepatitis A recently found in Gunma, Japan

M. Mori, T. Otsuka, M. Kaneko, 2002, Journal of Gastroenterology.

The natural history of untreated hepatocellular carcinoma

T. Nagamine, H. Takagi, T. Kosone, 1998, International Journal of Clinical Oncology.

Pilot clinical trial of the use of alpha-tocopherol for the prevention of hepatocellular carcinoma in patients with liver cirrhosis.

M. Mori, T. Nagamine, M. Kaneko, 2003, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

The possible role of zinc and metallothionein in the liver on the therapeutic effect of IFN-α to hepatitis C patients

M. Mori, T. Nagamine, H. Takagi, 1997, Biological Trace Element Research.

Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C

T. Nagamine, H. Takagi, T. Matsumoto, 2001, Journal of viral hepatitis.

Accidental transmission of HCV and treatment with interferon

M. Mori, T. Nagamine, S. Saito, 1998, Journal of gastroenterology and hepatology.

Case Report : Severe Type Hepatitis B with Cirrhotic Change Successfully Treated by Lamivudine and Achieved Marked Improvement of Hepatic Functional Reserve

M. Mori, H. Takagi, Y. Hashimoto, 2003 .

TANGIER DISEASE KINDRED DISCOVERED AS A RESULT OF COLONOSCOPIC EXAMINATION

J. Matsumoto, D. Kanda, Y. Hashimoto, 1998 .

Prevalence of hepatitis G virus in liver disease.

T. Nagamine, H. Takagi, T. Matsumoto, 1999, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Absence of specific symptoms in chronic hepatitis C

M. Mori, Shosuke Suzuki, M. Iwasaki, 2002, Journal of Gastroenterology.